Literature DB >> 12697645

Sequence analysis of cfxA2-like beta-lactamases in Prevotella species.

Chantal Giraud-Morin1, Isabelle Madinier, Thierry Fosse.   

Abstract

Sixty-two strains of oral (32) and non-oral (30) Prevotella producing beta-lactamases were screened for cfxA by PCR, using an intragenic primer pair. All 62 were cfxA/cfxA2 positive. Fourteen of these strains, representing seven pigmented and seven non-pigmented Prevotella species were submitted to further PCR with specific primers that amplified the whole beta-lactamase structural gene (966 bp). After cloning and sequencing, the deduced amino acid sequences were compared with that of Bacteroides vulgatus CfxA beta-lactamase. All 14 sequences possessed the E272K substitution characteristic of CfxA2. CfxA sensu stricto was not observed in the present series. G83D, F/V189L, W193L and D239Y substitutions were observed more than once, without species specificity. This sequence analysis indicates that most oral and non-oral beta-lactamase-producing Prevotella isolates from French patients produce variants of the CfxA enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697645     DOI: 10.1093/jac/dkg221

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Detection of cfxA and cfxA2, the beta-lactamase genes of Prevotella spp., in clinical samples from dentoalveolar infection by real-time PCR.

Authors:  Kaori Iwahara; Tomoari Kuriyama; Satoshi Shimura; David W Williams; Maki Yanagisawa; Kiyomasa Nakagawa; Tadahiro Karasawa
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Metallo-β-lactamase-producing bacteroides species can shield other members of the gut microbiota from antibiotics.

Authors:  Usha Stiefel; Mary Ann Tima; Michelle M Nerandzic
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

3.  Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.

Authors:  Laura J Sherrard; Bettina Schaible; Kathryn A Graham; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Matthew C Wolfgang; Marianne S Muhlebach; Deirdre F Gilpin; Thamarai Schneiders; J Stuart Elborn; Michael M Tunney
Journal:  J Antimicrob Chemother       Date:  2014-06-10       Impact factor: 5.790

Review 4.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

5.  Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota.

Authors:  Laura J Sherrard; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Matthew C Wolfgang; Marianne S Muhlebach; Deirdre F Gilpin; J Stuart Elborn; Michael M Tunney
Journal:  Int J Antimicrob Agents       Date:  2015-12-29       Impact factor: 5.283

6.  Draft Whole-Genome Sequences of Periodontal Pathobionts Porphyromonas gingivalis, Prevotella intermedia, and Tannerella forsythia Contain Phase-Variable Restriction-Modification Systems.

Authors:  Richard D Haigh; Liam A Crawford; Joseph D Ralph; Joseph J Wanford; Sonia R Vartoukian; Karolin Hijazi; William Wade; Marco R Oggioni
Journal:  Genome Announc       Date:  2017-11-16

7.  Detection of cfxA2, cfxA3, and cfxA6 genes in beta-lactamase producing oral anaerobes.

Authors:  Buhle Binta; Mrudula Patel
Journal:  J Appl Oral Sci       Date:  2016-04       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.